Cara Therapeutics, Inc. (CARA)
NASDAQ: CARA · Real-Time Price · USD
0.292
-0.005 (-1.75%)
Nov 4, 2024, 4:00 PM EST - Market closed
Cara Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Cash & Equivalents | 49.24 | 51.78 | 63.74 | 13.45 | 31.68 | 18.31 | Upgrade
|
| Short-Term Investments | 7.38 | 48.98 | 81.66 | 153.58 | 149.24 | 136.7 | Upgrade
|
| Cash & Short-Term Investments | 56.62 | 100.76 | 145.4 | 167.04 | 180.93 | 155.01 | Upgrade
|
| Cash Growth | -40.21% | -30.70% | -12.95% | -7.68% | 16.72% | -3.95% | Upgrade
|
| Accounts Receivable | 0.36 | 2.77 | 3.26 | - | - | - | Upgrade
|
| Other Receivables | 1.46 | 1.25 | 1.19 | 1.15 | 2.06 | 1.79 | Upgrade
|
| Receivables | 1.82 | 4.02 | 4.45 | 1.15 | 2.06 | 1.79 | Upgrade
|
| Inventory | 1.64 | 2.82 | 2.38 | 2.58 | - | - | Upgrade
|
| Prepaid Expenses | 3.78 | 8.15 | 16.27 | 2.52 | 12.08 | 8.86 | Upgrade
|
| Restricted Cash | - | 0.41 | 0.41 | - | - | - | Upgrade
|
| Total Current Assets | 63.86 | 116.16 | 168.91 | 173.29 | 195.07 | 165.66 | Upgrade
|
| Property, Plant & Equipment | 7.14 | 8.19 | 1.98 | 3.6 | 5.12 | 3.74 | Upgrade
|
| Long-Term Investments | - | - | 11.35 | 69.75 | 70.57 | 63.16 | Upgrade
|
| Other Long-Term Assets | 1.5 | 1.5 | - | 0.41 | 0.41 | 0.41 | Upgrade
|
| Total Assets | 72.5 | 125.84 | 182.24 | 247.06 | 271.16 | 232.96 | Upgrade
|
| Accounts Payable | 6.76 | 11.58 | 9.6 | 5.63 | 4.89 | 9.1 | Upgrade
|
| Accrued Expenses | 6.98 | 14.01 | 11.94 | 10.24 | 11.99 | 10.57 | Upgrade
|
| Current Portion of Leases | 0.17 | - | 1.92 | 1.76 | 1.6 | 0.97 | Upgrade
|
| Current Unearned Revenue | - | - | - | - | - | 22.26 | Upgrade
|
| Total Current Liabilities | 13.9 | 25.59 | 23.46 | 17.62 | 18.48 | 42.89 | Upgrade
|
| Long-Term Debt | 39.68 | 37.08 | - | - | - | - | Upgrade
|
| Long-Term Leases | 7.32 | 6.09 | - | 1.92 | 3.67 | 3.35 | Upgrade
|
| Total Liabilities | 60.9 | 68.76 | 23.46 | 19.53 | 22.16 | 46.25 | Upgrade
|
| Common Stock | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | Upgrade
|
| Additional Paid-In Capital | 747.12 | 742.04 | 726.63 | 708.59 | 641.2 | 587.22 | Upgrade
|
| Retained Earnings | -735.46 | -684.75 | -566.23 | -480.76 | -392.32 | -400.73 | Upgrade
|
| Comprehensive Income & Other | -0.12 | -0.26 | -1.67 | -0.36 | 0.07 | 0.17 | Upgrade
|
| Total Common Equity | 11.6 | 57.09 | 158.78 | 227.52 | 249 | 186.71 | Upgrade
|
| Shareholders' Equity | 11.6 | 57.09 | 158.78 | 227.52 | 249 | 186.71 | Upgrade
|
| Total Liabilities & Equity | 72.5 | 125.84 | 182.24 | 247.06 | 271.16 | 232.96 | Upgrade
|
| Total Debt | 47.16 | 43.17 | 1.92 | 3.67 | 5.28 | 4.32 | Upgrade
|
| Net Cash (Debt) | 9.45 | 57.59 | 154.83 | 233.12 | 246.22 | 213.85 | Upgrade
|
| Net Cash Growth | -90.62% | -62.80% | -33.58% | -5.32% | 15.14% | 17.00% | Upgrade
|
| Net Cash Per Share | 0.17 | 1.06 | 2.89 | 4.60 | 5.14 | 5.01 | Upgrade
|
| Filing Date Shares Outstanding | 54.85 | 54.66 | 53.94 | 53.51 | 49.88 | 46.73 | Upgrade
|
| Total Common Shares Outstanding | 54.84 | 54.48 | 53.8 | 53.48 | 49.87 | 46.72 | Upgrade
|
| Working Capital | 49.96 | 90.57 | 145.45 | 155.67 | 176.58 | 122.76 | Upgrade
|
| Book Value Per Share | 0.21 | 1.05 | 2.95 | 4.25 | 4.99 | 4.00 | Upgrade
|
| Tangible Book Value | 11.6 | 57.09 | 158.78 | 227.52 | 249 | 186.71 | Upgrade
|
| Tangible Book Value Per Share | 0.21 | 1.05 | 2.95 | 4.25 | 4.99 | 4.00 | Upgrade
|
| Machinery | - | 0.84 | 0.57 | 0.57 | 1.17 | 0.9 | Upgrade
|
| Leasehold Improvements | - | 4.15 | 1.27 | 1.22 | 1.21 | 1.13 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.